| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |